As shown in Figure 3A, irrespective of age, gender, baseline WBC count, or allo‐HSCT, a lower CD20 MFI suggested shorter survival time for ALL patients (all p‐values < 0.05). The gene discussed is MS4A1; the disease is acute lymphoblastic leukemia.